BlackRock Capital Allocation Term Trust is a US-based company operating in industry. The company is headquartered in Wilmington, Delaware. The company went IPO on 2020-09-25. BlackRock Capital Allocation Term Trust (the Trust) is a diversified, closed-end management investment company. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust invests in a portfolio of equity and debt securities. Generally, the Trust’s portfolio will include both equity and debt securities. At any given time, however, the Trust may emphasize either debt securities or equity securities. The Trust utilizes an option writing (selling) strategy in an effort to generate current gains from options premiums and to enhance the Trust’s risk-adjusted returns. The Trust can invest in all types of debt securities, including the United States and foreign government bonds, corporate bonds, convertible bonds, municipal bonds, structured notes, credit-linked notes, loan assignments and participations, and others. The Trust’s investment adviser is BlackRock Advisors, LLC.
BlackRock Capital Allocation Term Trust 的關鍵財務報表是什麼?
根據最新的財務報表(Form-10K),BlackRock Capital Allocation Term Trust 的總資產為 $1,966,淨利潤為 $222
BCAT 的關鍵財務比率是什麼?
BlackRock Capital Allocation Term Trust 的流動比率為 5.31,淨利潤率為 370,每股銷售為 $0.57。
BlackRock Capital Allocation Term Trust 的收入按細分市場或地理位置如何劃分?
BlackRock Capital Allocation Term Trust 最大收入來源為 Genetic Medicines,在最近的收益報告中收入為 63,518,000。就地區而言,United States 是 BlackRock Capital Allocation Term Trust 的主要市場,收入為 63,518,000。
BlackRock Capital Allocation Term Trust 是否盈利?
是的,根據最新的財務報表,BlackRock Capital Allocation Term Trust 的淨利潤為 $222
BlackRock Capital Allocation Term Trust 有負債嗎?
是的,BlackRock Capital Allocation Term Trust 的負債為 370
BlackRock Capital Allocation Term Trust 的流通股有多少?
BlackRock Capital Allocation Term Trust 的總流通股為 105